Recent Advancements in Esoteric Testing for Increased Accuracy

Published: Apr 2024

Global esoteric testing market is anticipated to grow at a CAGR of 11.0% during the forecast period (2024-2031). The market growth is driven by the growing geriatric population, increasing prevalence of chronic and infectious diseases, advancing escortic DNA (Deoxyribonucleic Acid) sequencing technologies in precision medicine, early diagnosis of cancer and precision medicine. Additionally, the emergence of other technologies such as biomarker analysis, digital PCR, NCS, didgital microfluid platforms, advanced phenotyping technologies and more are presenting a considerable opportunity for market growth.

Browse the full report description of “Esoteric Testing Market Size, Share & Trends Analysis Report by Test Type (Infectious Disease Testing, Oncology Testing, Endocrinology Testing, Genetic Testing, Toxicology, Neurology Testing, and Others), By Technology (Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Mass Spectrometry, DNA Sequencing, Flow Cytometry, Others), and by End-User (Hospital-based Laboratories and Independent and Reference Laboratories) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/esoteric-testing-market

In July 2023, Quest Diagnostics®, launched a consumer-initiated genetic test, namely ‘Genetic Insights’, on its platform. The test is based-on sequencing, robust support services, physician ordering, and access to one-on-one genetic counseling, and provides insights based on DNA. The test helps people to helps people understand their potential risk of developing certain inheritable health conditions.

In June 2022, SRL Diagnostics launched a laboratory at Ashok Nagar, Chennai. The laboratory has the capability to conduct more than one lakh tests each month, including the most routine tests to esoteric and genetic tests.

In June 2022, Sentinel CH. SpA (Sentinel Diagnostics), launched SENTiFIT®800, an automated, high-throughput instrument for fecal tests. It is suitable for FIT screening programs and laboratories that process high volume of samples. It reduce the operator hands-on time and Increase the laboratory efficiency.

Market Coverage

The market number available for – 2023-2031

Base year- 2023

Forecast period- 2024-2031

Segment Covered- 

o By Test Type

o By Technology

o By End-User

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- Laboratory Corp. (Labcorp)/ Laboratory Corp. of America, OPKO Health, Inc., Quest Diagnostics, F. Hoffmann-La Roche Ltd., and Mayo Clinic (Mayo Foundation for Medical Education and Research), among others.

Key questions addressed by the report.

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Esoteric Testing Market Report Segment

By Test Type

  • Infectious Disease Testing
  • Oncology Testing
  • Endocrinology Testing
  • Genetic Testing
  • Toxicology Testing
  • Neurology Testing
  • Other Testing (Immunology Testing)

By Technology

  • Enzyme-linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Mass Spectrometry
  • DNA Sequencing
  • Flow Cytometry
  • Others (Radio Immunoassays, Real Time Polymerase Chain Reaction (PCR))

By End-User

  • Hospital-based Laboratories
  • Independent and Reference Laboratories

Global Esoteric Testing Market Report Segment by Region

North America

United States

Canada 

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

The Middle East & Africa


To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/esoteric-testing-market